Former Stanford employee guilty of illegally accessing, altering breast cancer database
A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast ...
Blood Tests And Breastmilk: Why Investors Are Betting Big On Female Biology
As we enter 2025, the confluence of scientific advancement, market opportunity and industry validation suggests women's ...
Sierra Sun Times3h
Former Stanford Research Coordinator Convicted for Unlawfully Accessing and Altering Breast Cancer Study Database Hours After Being Fired
Former Stanford Research Coordinator Convicted for Unlawfully Accessing and Altering Breast Cancer Study Database Hours After ...
Crime and Public Safety
A jury found Naheed Mangi replaced patient medical data with erroneous information, insults about former boss.
FiercePharma6d
Genentech, Novartis join forces to raise awareness of food allergies’ impact on families
Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...
FierceBiotech13d
Genentech archives diversity reports amid site update, examines ‘potential implications of executive orders’
Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and ...
Pharm Exec5d
Genentech, Novartis, and FARE Partner for Food Allergy Educational Campaign
The campaign is based on the results of a survey that reveals the experiences of patients and caregivers in their communities ...
Hosted on MSN13d
Drugmaker Roche’s US Biotech Unit Pulls DEI Targets From Website
Genentech had aimed by this year to double Black and Hispanic representation of directors and officers and extended leadership, among a range of commitments listed on reports and a version of its ...
Ex-Stanford employee altered breast cancer study data after being fired: DOJ
A former Stanford employee was convicted of altering data used in a breast cancer study after she was fired, according to the United States Department of Justice. Naheed Mangi, 66, ...
If this biotech CEO succeeds millions of cancer patients could benefit
If this CEO succeeds N-Power could save millions of dollars and lives in the fight against cancer. "The impact for cancer ...
Business Wire22d
FDA Approves Genentech’s Susvimo as the First and Only Continuous Delivery Treatment for the Leading Cause of Diabetes-Related Blindness
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved Susvimo ...
Business Wire14d
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New ...